Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| fibroblast | 33 studies | 37% ± 17% | |
| endothelial cell | 29 studies | 32% ± 14% | |
| endothelial cell of lymphatic vessel | 24 studies | 51% ± 21% | |
| naive thymus-derived CD4-positive, alpha-beta T cell | 13 studies | 24% ± 6% | |
| basal cell | 12 studies | 37% ± 9% | |
| vein endothelial cell | 11 studies | 39% ± 22% | |
| pericyte | 10 studies | 34% ± 19% | |
| endothelial cell of vascular tree | 10 studies | 38% ± 18% | |
| smooth muscle cell | 9 studies | 30% ± 12% | |
| connective tissue cell | 9 studies | 37% ± 16% | |
| glutamatergic neuron | 9 studies | 38% ± 12% | |
| astrocyte | 8 studies | 39% ± 24% | |
| oligodendrocyte precursor cell | 8 studies | 21% ± 4% | |
| adipocyte | 8 studies | 33% ± 12% | |
| neuron | 7 studies | 39% ± 27% | |
| myofibroblast cell | 7 studies | 43% ± 22% | |
| GABAergic neuron | 7 studies | 28% ± 10% | |
| interneuron | 6 studies | 28% ± 19% | |
| ciliated cell | 6 studies | 24% ± 6% | |
| Mueller cell | 6 studies | 38% ± 11% | |
| club cell | 5 studies | 31% ± 10% | |
| epithelial cell | 5 studies | 35% ± 13% | |
| adventitial cell | 5 studies | 37% ± 20% | |
| regulatory T cell | 5 studies | 20% ± 2% | |
| respiratory goblet cell | 4 studies | 39% ± 11% | |
| secretory cell | 4 studies | 33% ± 9% | |
| cholangiocyte | 4 studies | 63% ± 19% | |
| hepatocyte | 4 studies | 76% ± 19% | |
| capillary endothelial cell | 4 studies | 30% ± 10% | |
| myoepithelial cell | 4 studies | 68% ± 21% | |
| CD4-positive, alpha-beta memory T cell | 3 studies | 17% ± 3% | |
| duct epithelial cell | 3 studies | 30% ± 1% | |
| hepatic stellate cell | 3 studies | 47% ± 20% | |
| progenitor cell | 3 studies | 38% ± 20% | |
| abnormal cell | 3 studies | 59% ± 15% | |
| mesothelial cell | 3 studies | 37% ± 22% | |
| granule cell | 3 studies | 48% ± 30% | |
| lymphocyte | 3 studies | 33% ± 20% | |
| glycinergic amacrine cell | 3 studies | 28% ± 6% | |
| endothelial cell of artery | 3 studies | 32% ± 3% | |
| CD4-positive, alpha-beta T cell | 3 studies | 30% ± 10% | |
| chondrocyte | 3 studies | 28% ± 9% | |
| T follicular helper cell | 3 studies | 25% ± 4% | |
| mucus secreting cell | 3 studies | 56% ± 15% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| ovary | 100% | 4715.54 | 180 / 180 | 95% | 7.50 | 409 / 430 |
| esophagus | 99% | 1191.38 | 1433 / 1445 | 92% | 6.49 | 169 / 183 |
| adrenal gland | 100% | 3011.17 | 258 / 258 | 91% | 6.97 | 209 / 230 |
| prostate | 100% | 1239.19 | 244 / 245 | 90% | 3.13 | 454 / 502 |
| breast | 100% | 3165.76 | 459 / 459 | 87% | 4.74 | 972 / 1118 |
| liver | 99% | 925.53 | 223 / 226 | 88% | 4.89 | 358 / 406 |
| uterus | 100% | 2352.48 | 170 / 170 | 79% | 4.47 | 362 / 459 |
| stomach | 96% | 956.08 | 345 / 359 | 71% | 4.20 | 203 / 286 |
| lung | 85% | 674.36 | 489 / 578 | 80% | 3.79 | 927 / 1155 |
| bladder | 95% | 1356.48 | 20 / 21 | 56% | 2.22 | 284 / 504 |
| thymus | 99% | 1398.95 | 647 / 653 | 52% | 1.17 | 312 / 605 |
| pancreas | 55% | 277.83 | 179 / 328 | 93% | 9.19 | 166 / 178 |
| intestine | 86% | 1320.05 | 832 / 966 | 53% | 2.32 | 280 / 527 |
| skin | 88% | 976.47 | 1592 / 1809 | 33% | 1.43 | 158 / 472 |
| brain | 50% | 323.56 | 1315 / 2642 | 61% | 2.04 | 432 / 705 |
| adipose | 100% | 3580.02 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| kidney | 49% | 361.13 | 44 / 89 | 50% | 1.85 | 452 / 901 |
| spleen | 98% | 927.46 | 237 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 91% | 4.20 | 41 / 45 |
| blood vessel | 79% | 697.34 | 1061 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 76% | 2.20 | 22 / 29 |
| heart | 66% | 439.10 | 568 / 861 | 0% | 0 | 0 / 0 |
| muscle | 29% | 152.80 | 236 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 4% | 18.11 | 39 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_0000785 | Cellular component | chromatin |
| GO_0005634 | Cellular component | nucleus |
| GO_0003677 | Molecular function | DNA binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
| GO_0046872 | Molecular function | metal ion binding |
| Gene name | TSHZ2 |
| Protein name | TSHZ2 protein Cell growth-inhibiting protein 7 (HCG1784586) (Teashirt zinc finger homeobox 2) Teashirt homolog 2 (Ovarian cancer-related protein 10-2) (OVC10-2) (Zinc finger protein 218) Teashirt zinc finger homeobox 2 |
| Synonyms | ZNF218 C20orf17 hCG_1784586 TSH2 |
| Description | FUNCTION: Probable transcriptional regulator involved in developmental processes. May act as a transcriptional repressor (Potential). . |
| Accessions | S4R3C8 Q9NRE2 A7E1X4 ENST00000605656.2 B1H0U8 ENST00000626626.1 ENST00000603338.2 [Q9NRE2-2] ENST00000371497.10 [Q9NRE2-1] |